Published in J Adolesc Health on March 01, 1998
Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol (2008) 2.96
Vaginal douching: evidence for risks or benefits to women's health. Epidemiol Rev (2002) 1.71
Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens. J Clin Microbiol (1999) 1.60
Comparison of the PACE 2 assay, two amplification assays, and Clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens. J Clin Microbiol (1999) 1.28
Vaginal douching and risk of preterm birth among African American women. Am J Obstet Gynecol (2007) 0.89
Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis. PLoS One (2015) 0.87
Prevalence and correlates of recent vaginal douching among African American adolescent females. J Pediatr Adolesc Gynecol (2011) 0.81
Rapid hybridization probe assay and PCR for detection of Chlamydia trachomatis in urinary tract infections: a prospective study. Curr Microbiol (2006) 0.75
High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother (1986) 6.34
Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50
Detection of antibodies to legionnaires disease organism by microagglutination and micro-enzyme-linked immunosorbent assay tests. J Clin Microbiol (1978) 4.45
Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer (1989) 4.34
Factors affecting autolysis of Neisseria gonorrhoeae. Proc Soc Exp Biol Med (1974) 4.00
Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci U S A (2006) 3.97
Specificity and function of T cells bearing gamma delta receptors. Immunol Today (1988) 3.93
T-cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol Rev (1989) 3.80
Predictions of hospital mortality rates: a comparison of data sources. Ann Intern Med (1997) 3.72
Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline. J Infect Dis (1987) 3.62
Adaptation of the Minitek system for the rapid identification of Neisseria gonorrhoeae. J Clin Microbiol (1976) 3.58
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol (1980) 3.32
CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem (2001) 3.28
Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nat Med (1999) 3.27
Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) (2004) 3.12
Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia. J Clin Microbiol (1993) 3.04
Glucose metabolism in Neisseria gonorrhoeae. J Bacteriol (1974) 3.01
Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med (1995) 3.00
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol (1993) 2.92
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis (2003) 2.85
Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature (1981) 2.85
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Measure of immunoglobulin G-, M-, and A-specific titers against Legionella pneumophila and inhibition of titers against nonspecific, gram-negative bacterial antigens in the indirect immunofluorescence test for legionellosis. J Clin Microbiol (1979) 2.84
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? J Rheumatol (1994) 2.76
Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med (1979) 2.76
Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis (2000) 2.71
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Limbic lesions and the problem of stimulus--reinforcement associations. Exp Neurol (1972) 2.65
The specificity of fetal IgM: antibody or anti-antibody? Ann N Y Acad Sci (1975) 2.65
Helping health professionals involved in cancer care acquire key interviewing skills--the impact of workshops. Eur J Cancer (1996) 2.62
In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med (1990) 2.61
Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun (1982) 2.55
Detection of Legionella pneumonophila antigen in urine by enzyme-linked immunospecific assay. J Clin Microbiol (1979) 2.54
Nutritional requirements of Staphylococcus aureus S-6. Appl Microbiol (1967) 2.51
Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol (1976) 2.49
Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984. J Infect Dis (1986) 2.49
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet (1995) 2.49
Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47
The promise of integrated representative surveys about sexually transmitted diseases and behavior. Sex Transm Dis (1997) 2.44
Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis (1998) 2.44
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Olfactory deficits in schizophrenia. Biol Psychiatry (1988) 2.38
Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice. Br J Gen Pract (2001) 2.38
Further observations on the persistence of Treponema pallidum after treatment in rabbits and humans. Br J Vener Dis (1968) 2.37
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Absence of superoxide dismutase in some strains of Neisseria gonorrhoeae. Biochem Biophys Res Commun (1979) 2.31
Chancroid and Haemophilus ducreyi: an update. Clin Microbiol Rev (1995) 2.30
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis (2006) 2.28
Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis (1998) 2.27
Regulation of staphylococcal enterotoxin B. J Bacteriol (1969) 2.27
Human immunodeficiency virus infection among Peace Corps volunteers in Zaire. No evidence for unusual modes of transmission. Arch Intern Med (1991) 2.25
Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ (2011) 2.21
Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity (1999) 2.19
Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis. J Clin Microbiol (1998) 2.14
Vagal reflexes referred from the upper aerodigestive tract: an infrequently recognized cause of common cardiorespiratory responses. Ann Intern Med (1992) 2.14
A bookshelf in public health, medical care, and allied fields. Bull Med Libr Assoc (1972) 2.14
Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM (2007) 2.14
High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella denitrificans, and Eikenella corrodens. Antimicrob Agents Chemother (1988) 2.11
Recurrent urinary infections in girls: relation to enuresis. Can Med Assoc J (1972) 2.09
Older people's views of advice about falls prevention: a qualitative study. Health Educ Res (2006) 2.08
Purine metabolism in Neisseria gonorrhoeae: the requirement for hypoxanthine. Can J Microbiol (1980) 2.08
Isolation of a lipopolysaccharide mutant of Neisseria gonorrhoeae: an analysis of the antigenic and biologic difference. J Infect Dis (1982) 2.08
Role of superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: importance in resistance to microbicidal activities of human polymorphonuclear neutrophils. Infect Immun (1985) 2.06
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol (1997) 2.00
Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology (1995) 1.95
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis. Rheumatology (Oxford) (2006) 1.94
The role of iron-binding proteins in the survival of pathogenic bacteria. Annu Rev Nutr (1994) 1.93
Age-related changes in marathon and half-marathon performances. Int J Sports Med (2007) 1.91
Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation. Eur J Immunol (1982) 1.91
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis (2000) 1.89
Cell envelope of Neisseria gonorrhoeae: relationship between autolysis in buffer and the hydrolysis of peptidoglycan. Infect Immun (1977) 1.88
Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother (1980) 1.86
Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum (1996) 1.85
Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol (1988) 1.83
Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology (Oxford) (2008) 1.83
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Comparison of arbitrarily primed polymerase chain reaction, ribotyping, and monoclonal antibody analysis for subtyping Legionella pneumophila serogroup 1. J Clin Microbiol (1993) 1.82
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) (2001) 1.82
Replantation. Br Med J (Clin Res Ed) (1983) 1.81
Microtiter hemagglutination-inhibition assay for staphylococcal enterotoxin B. Appl Microbiol (1967) 1.81
Identification of an iron-regulated 37,000-dalton protein in the cell envelope of Neisseria gonorrhoeae. Infect Immun (1984) 1.79
A pilot study of the prevalence of chlamydial infection in a national household survey. Sex Transm Dis (1998) 1.78
Identification and cloning of a fur homolog from Neisseria gonorrhoeae. Infect Immun (1993) 1.78
CT evaluation of amyloidosis: spectrum of disease. Radiographics (1993) 1.77
Insertion of Tn916 in Neisseria meningitidis resulting in loss of group B capsular polysaccharide. Infect Immun (1991) 1.77
Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet (1991) 1.76
Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet (1991) 1.76
Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol (1996) 1.76
Sodium desoxycholate-extracted treponemal antigen in an enzyme-linked immunosorbent assay for syphilis. J Clin Microbiol (1982) 1.75
Prevalence of aspiration and laryngeal penetration in patients with unilateral vocal fold motion impairment. Dysphagia (2000) 1.75
Effect of progesterone on Neisseria gonorrhoeae. Infect Immun (1974) 1.75